JP2025509152A5 - - Google Patents
Info
- Publication number
- JP2025509152A5 JP2025509152A5 JP2024552013A JP2024552013A JP2025509152A5 JP 2025509152 A5 JP2025509152 A5 JP 2025509152A5 JP 2024552013 A JP2024552013 A JP 2024552013A JP 2024552013 A JP2024552013 A JP 2024552013A JP 2025509152 A5 JP2025509152 A5 JP 2025509152A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2203070.4A GB202203070D0 (en) | 2022-03-04 | 2022-03-04 | Anti-canag antibody conjugate |
| GB2203070.4 | 2022-03-04 | ||
| PCT/GB2023/050522 WO2023166322A1 (en) | 2022-03-04 | 2023-03-06 | Anti-canag antibody conjugate |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025509152A JP2025509152A (ja) | 2025-04-11 |
| JP2025509152A5 true JP2025509152A5 (https=) | 2026-01-26 |
| JPWO2023166322A5 JPWO2023166322A5 (https=) | 2026-01-26 |
Family
ID=81175257
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024552013A Pending JP2025509152A (ja) | 2022-03-04 | 2023-03-06 | 抗ＣａｎＡｇ抗体複合体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250213711A1 (https=) |
| EP (1) | EP4486392A1 (https=) |
| JP (1) | JP2025509152A (https=) |
| KR (1) | KR20240163656A (https=) |
| CN (1) | CN119136841A (https=) |
| AU (1) | AU2023229192A1 (https=) |
| GB (1) | GB202203070D0 (https=) |
| IL (1) | IL315428A (https=) |
| WO (1) | WO2023166322A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2018308088B2 (en) | 2017-07-25 | 2025-05-29 | Truebinding, Inc. | Treating cancer by blocking the interaction of TIM-3 and its ligand |
| AU2020214796A1 (en) | 2019-01-30 | 2021-07-29 | Truebinding, Inc. | Anti-Gal3 antibodies and uses thereof |
| WO2021242776A2 (en) | 2020-05-26 | 2021-12-02 | Truebinding, Inc. | Methods of treating inflammatory diseases by blocking galectin-3 |
| GB202313214D0 (en) * | 2023-08-30 | 2023-10-11 | Iksuda Therapeutics Ltd | Co-administration of antibody-drug conjugate |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE045348T2 (hu) | 2011-05-08 | 2019-12-30 | Legochem Biosciences Inc | Fehérje-hatóanyag konjugátumok és eljárás elõállításukra |
| KR101628872B1 (ko) | 2014-05-28 | 2016-06-09 | 주식회사 레고켐 바이오사이언스 | 자가-희생 기를 포함하는 화합물 |
| HRP20240795T1 (hr) | 2015-11-25 | 2024-09-13 | Ligachem Biosciences Inc. | Konjugati koji se sastoje od samozapaljujućih skupina i postupci povezani s njima |
| KR102847350B1 (ko) | 2015-11-25 | 2025-08-19 | 주식회사 리가켐바이오사이언스 | 분지된 링커를 포함하는 항체-약물 접합체 및 이의 제조방법 |
| MX2019011655A (es) * | 2017-03-29 | 2019-12-19 | Legochem Biosciences Inc | Profarmaco de dimero de pirrolobenzodiazepina y compuesto conjugado ligando-conector de este. |
| WO2018182341A1 (ko) | 2017-03-29 | 2018-10-04 | 주식회사 레고켐 바이오사이언스 | 피롤로벤조디아제핀 이량체 전구체 및 이의 리간드-링커 접합체 화합물 |
| EP3950061A4 (en) * | 2019-03-25 | 2022-11-16 | Daiichi Sankyo Company, Limited | ANTIBODY PYRROLOBENZODIAZEPINE DERIVATIVE CONJUGATE |
-
2022
- 2022-03-04 GB GBGB2203070.4A patent/GB202203070D0/en not_active Ceased
-
2023
- 2023-03-06 US US18/843,659 patent/US20250213711A1/en active Pending
- 2023-03-06 WO PCT/GB2023/050522 patent/WO2023166322A1/en not_active Ceased
- 2023-03-06 IL IL315428A patent/IL315428A/en unknown
- 2023-03-06 EP EP23711533.2A patent/EP4486392A1/en active Pending
- 2023-03-06 AU AU2023229192A patent/AU2023229192A1/en active Pending
- 2023-03-06 CN CN202380037771.5A patent/CN119136841A/zh active Pending
- 2023-03-06 JP JP2024552013A patent/JP2025509152A/ja active Pending
- 2023-03-06 KR KR1020247032787A patent/KR20240163656A/ko active Pending